Corporate Presentation 1 January 2023 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955 ("PSLRA") relating to, among other things, expected commercial and financial results for the fourth quarter and fiscal year ended December 31, 2022; Rigel's ability to earn and receive milestone payments; expectations related to the potential and market opportunity of olutasidenib as therapeutics for R/R AML and othe ...